← Leaderboards
Brendan Hl Lee
Baylor College Of Medicine
$62,781,623
Attributed
$85,717,889
Total exposure
91
Grants
76
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $15.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$122,779,492 · 95
By mechanism
P01$29,245,500 · 13
U54$26,699,411 · 14
R01$24,800,251 · 14
U01$16,862,454 · 2
UC2$10,788,004 · 1
T32$6,572,546 · 1
Top collaborators
- Carlos Alberto Bacino13 shared
- Dongsu Park9 shared
- David Loren Nelson6 shared
- Jeffrey L Neul6 shared
- Benjamin R Arenkiel4 shared
- Stephen D Cederbaum4 shared
- Cynthia Le Mons4 shared
- Debra Dianne Murray4 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Russell S Ray$12,671,167
- Benjamin R Arenkiel$15,090,250
- Dongsu Park$5,989,378
- Joshua D. Wythe$3,990,787
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchPhenotypeBaseOsteogenesis ImperfectaMutationResearch PersonnelGeneticUnited States National Institutes Of HealthAffectBoneRare DiseasesGenotypeResourcesBiochemicalGenesFundingCellsDefectBone DiseasesCollegeMedicineComplexLeadMolecular
Grant awards (200)
Neuronal anatomy, connectivity, and phenotypic innervation of the knee joint$2,460,714
UC2 · FY2025 · AR · contact PI
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network$1,602,789
U54 · FY2025 · AR · contact PI
Increasing the Efficiency of RE-JOIN Through Data Sharing and Integration$842,580
UC2 · FY2025 · AR · contact PI
UDN Diagnostic Center of Excellence at Baylor College of Medicine$794,101
U01 · FY2025 · NS · contact PI
MAGNET: MAKING GENOMICS ACCESSIBLE FOR NEWBORNS IN TEXAS$705,600
R01 · FY2025 · HG · contact PI
Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta$662,355
R01 · FY2025 · DE
Medical Genetics Research Fellowship Program$652,030
T32 · FY2025 · GM · contact PI
Targeting TGFb In Osteogenesis Imperfecta$607,076
R01 · FY2025 · AR
WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues$576,000
R01 · FY2025 · DE · contact PI
BBDC RDCRN Administrative Core$165,486
U54 · FY2025 · AR · contact PI
ASBMR-RBDA Three-Year Rare Bone Disease Symposia$45,000
R13 · FY2025 · AR · contact PI
Pilot Feasability$12,567
U54 · FY2025 · AR · contact PI
UDN Diagnostic Center of Excellence at Baylor College of Medicine$794,101
U01 · FY2024 · NS · contact PI
MAGNET: MAKING GENOMICS ACCESSIBLE FOR NEWBORNS IN TEXAS$705,600
R01 · FY2024 · HG · contact PI
ALL OF US EVENINGS WITH GENETICS RESEARCH EDUCATION PROGRAM$690,020
OT2 · FY2024 · OD
Medical Genetics Research Fellowship Program$670,335
T32 · FY2024 · GM · contact PI
Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta$649,109
R01 · FY2024 · DE
Targeting TGFb In Osteogenesis Imperfecta$607,076
R01 · FY2024 · AR
WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues$564,480
R01 · FY2024 · DE · contact PI
Neuronal anatomy, connectivity, and phenotypic innervation of the knee joint$96,000
UC2 · FY2024 · AR · contact PI
ASBMR-RBDA Three-Year Rare Bone Disease Symposia$45,000
R13 · FY2024 · AR · contact PI
ALL OF US EVENINGS WITH GENETICS RESEARCH EDUCATION PROGRAM$1,675,468
OT2 · FY2023 · OD · contact PI
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK$1,389,055
U54 · FY2023 · AR · contact PI
PROJECT 1: LONGITUDINAL STUDIES$1,103,855
U54 · FY2023 · AR · contact PI
Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta$662,355
R01 · FY2023 · DE
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase III (U01)$628,000
U01 · FY2023 · NS · contact PI
Targeting TGFb In Osteogenesis Imperfecta$625,851
R01 · FY2023 · AR
Medical Genetics Research Fellowship Program$604,268
T32 · FY2023 · GM · contact PI
WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues$576,000
R01 · FY2023 · DE · contact PI
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase III (U01)$314,000
U01 · FY2023 · NS · contact PI
PROJECT 2: INVISALIGN TRIAL$109,200
U54 · FY2023 · AR · contact PI
ADMIN CORE$80,000
U54 · FY2023 · AR · contact PI
PILOT-FEASIBILITY$24,000
U54 · FY2023 · AR · contact PI
Neuronal anatomy, connectivity, and phenotypic innervation of the knee joint$7,388,710
UC2 · FY2022 · AR · contact PI
ALL OF US EVENINGS WITH GENETICS RESEARCH EDUCATION PROGRAM$1,675,468
OT2 · FY2022 · OD · contact PI
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK$1,438,582
U54 · FY2022 · AR · contact PI
PROJECT 1: LONGITUDINAL STUDIES$1,103,855
U54 · FY2022 · AR · contact PI
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)$785,098
U01 · FY2022 · HG · contact PI
Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta$662,355
R01 · FY2022 · DE
Medical Genetics Research Fellowship Program$595,211
T32 · FY2022 · GM · contact PI
WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues$570,241
R01 · FY2022 · DE · contact PI
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK$329,961
U54 · FY2022 · AR · contact PI
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK$323,774
U54 · FY2022 · AR · contact PI
Virtual Platforms for Genetics Evaluation in the Medically Underserved$317,000
UG3 · FY2022 · TR
PROJECT 2: INVISALIGN TRIAL$109,200
U54 · FY2022 · AR · contact PI
ADMIN CORE$80,000
U54 · FY2022 · AR · contact PI
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)$31,094
U01 · FY2022 · HG · contact PI
PILOT-FEASIBILITY$24,000
U54 · FY2022 · AR · contact PI
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK$1,389,055
U54 · FY2021 · AR · contact PI
PROJECT 1: LONGITUDINAL STUDIES$1,103,855
U54 · FY2021 · AR · contact PI
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)$1,100,000
U01 · FY2021 · HG · contact PI
ALL OF US EVENINGS WITH GENETICS RESEARCH EDUCATION PROGRAM$1,089,071
OT2 · FY2021 · OD
WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues$576,000
R01 · FY2021 · DE · contact PI
Medical Genetics Research Fellowship Program$558,397
T32 · FY2021 · GM · contact PI
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK$314,781
U54 · FY2021 · AR · contact PI
Expanding and sustaining UDN clinical site operations by leveraging a virtual platform for genetic services delivery$150,000
U01 · FY2021 · HG · contact PI
Pilot of New Technologies to Increase the Genomic Diagnosis of Undiagnosed Disease Network (UDN) Patients$149,922
U01 · FY2021 · HG · contact PI
PROJECT 2: INVISALIGN TRIAL$109,200
U54 · FY2021 · AR · contact PI
ADMIN CORE$80,000
U54 · FY2021 · AR · contact PI
DIVERSITY SUPPLEMENT: BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK$64,528
U54 · FY2021 · AR · contact PI
PILOT-FEASIBILITY$24,000
U54 · FY2021 · AR · contact PI
BCM Center for Precision Medicine Models$1,989,483
U54 · FY2020 · OD
Pathogenesis of Novel Forms of Osteogenesis Imperfecta$1,412,624
P01 · FY2020 · HD · contact PI
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK$1,389,055
U54 · FY2020 · AR · contact PI
PROJECT 1: LONGITUDINAL STUDIES$1,103,855
U54 · FY2020 · AR · contact PI
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)$1,100,000
U01 · FY2020 · HG · contact PI
Medical Genetics Research Fellowship Program$570,100
T32 · FY2020 · GM · contact PI
Project 1: The role of WNT1 signaling in osteogenesis imperfecta$429,614
P01 · FY2020 · HD · contact PI
Nitric Oxide and Bone Homeostasis in Patients with Argininosuccinate Lyase Deficiency$418,440
R01 · FY2020 · AR · contact PI
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK$232,935
U54 · FY2020 · AR · contact PI
PROJECT 2: INVISALIGN TRIAL$109,200
U54 · FY2020 · AR · contact PI
BCM: Administrative Core$100,243
P01 · FY2020 · HD · contact PI
ADMIN CORE$80,000
U54 · FY2020 · AR · contact PI
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)$75,000
U01 · FY2020 · HG · contact PI
PILOT-FEASIBILITY$24,000
U54 · FY2020 · AR · contact PI
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)$1,500,000
U01 · FY2019 · HG · contact PI
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK$1,470,655
U54 · FY2019 · AR · contact PI
Pathogenesis of Novel Forms of Osteogenesis Imperfecta$1,412,624
P01 · FY2019 · HD · contact PI
PROJECT 1: LONGITUDINAL STUDIES$1,170,455
U54 · FY2019 · AR · contact PI
Medical Genetics Research Fellowship Program$527,522
T32 · FY2019 · GM · contact PI
Project 1: The role of WNT1 signaling in osteogenesis imperfecta$429,614
P01 · FY2019 · HD · contact PI
Nitric Oxide and Bone Homeostasis in Patients with Argininosuccinate Lyase Deficiency$402,996
R01 · FY2019 · AR · contact PI
Clinical Translational$231,388
U54 · FY2019 · HD · contact PI
PROJECT 2: INVISALIGN TRIAL$109,200
U54 · FY2019 · AR · contact PI
BCM: Administrative Core$100,243
P01 · FY2019 · HD · contact PI
ADMIN CORE$80,000
U54 · FY2019 · AR · contact PI
PILOT-FEASIBILITY$24,000
U54 · FY2019 · AR · contact PI
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)$1,430,000
U01 · FY2018 · HG · contact PI
Pathogenesis of Novel Forms of Osteogenesis Imperfecta$1,412,624
P01 · FY2018 · HD · contact PI
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network$1,261,485
U54 · FY2018 · AR · contact PI
BCM CLINICAL SITE FOR AN UNDIAGNOSED DISEASES NETWORK (UDN)$766,667
U01 · FY2018 · HG · contact PI
Medical Genetics Research Fellowship Program$480,641
T32 · FY2018 · GM · contact PI
Argininosuccinate lyase is an essential regulator of systemic nitric oxide produc$455,904
R01 · FY2018 · DK · contact PI
Project 1: The role of WNT1 signaling in osteogenesis imperfecta$429,614
P01 · FY2018 · HD · contact PI
Nitric Oxide and Bone Homeostasis in Patients with Argininosuccinate Lyase Deficiency$402,996
R01 · FY2018 · AR · contact PI
Role of Nitric Oxide in Pathogenesis of Alzheimer's Disease$396,250
R01 · FY2018 · DK · contact PI
Clinical Translational$245,549
U54 · FY2018 · HD · contact PI
BCM: Administrative Core$100,243
P01 · FY2018 · HD · contact PI
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network$77,180
U54 · FY2018 · AR · contact PI
Mechanistic and Therapeutic Advances in Rare Skeletal Disease$35,000
R13 · FY2018 · AR · contact PI
BCM CLINICAL SITE FOR AN UNDIAGNOSED DISEASES NETWORK (UDN)$2,257,050
U01 · FY2017 · HG · contact PI
Pathogenesis of Novel Forms of Osteogenesis Imperfecta$1,412,624
P01 · FY2017 · HD · contact PI
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network$1,261,485
U54 · FY2017 · AR · contact PI
Argininosuccinate lyase is an essential regulator of systemic nitric oxide produc$455,904
R01 · FY2017 · DK · contact PI
Project 1: The role of WNT1 signaling in osteogenesis imperfecta$429,614
P01 · FY2017 · HD · contact PI
Nitric Oxide and Bone Homeostasis in Patients with Argininosuccinate Lyase Deficiency$402,996
R01 · FY2017 · AR · contact PI
Medical Genetics Research Fellowship Program$345,830
T32 · FY2017 · GM · contact PI
Clinical Translational$245,549
U54 · FY2017 · HD · contact PI
BCM: Administrative Core$100,243
P01 · FY2017 · HD · contact PI
BCM CLINICAL SITE FOR AN UNDIAGNOSED DISEASES NETWORK (UDN)$2,270,067
U01 · FY2016 · HG · contact PI
Pathogenesis of Novel Forms of Osteogenesis Imperfecta$1,441,874
P01 · FY2016 · HD · contact PI
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network$1,261,485
U54 · FY2016 · AR · contact PI
Argininosuccinate lyase is an essential regulator of systemic nitric oxide produc$473,609
R01 · FY2016 · DK · contact PI
Project 1: The role of WNT1 signaling in osteogenesis imperfecta$429,614
P01 · FY2016 · HD · contact PI
Medical Genetics Research Fellowship Program$391,068
T32 · FY2016 · GM · contact PI
Clinical Translational$245,549
U54 · FY2016 · HD · contact PI
Administrative Supplement: BCM Clinical Site for an Undiagnosed Diseases Network (UDN)S2$133,000
U01 · FY2016 · HG · contact PI
BCM: Administrative Core$100,243
P01 · FY2016 · HD · contact PI
BCM CLINICAL SITE FOR AN UNDIAGNOSED DISEASES NETWORK (UDN)$1,784,354
U01 · FY2015 · HG · contact PI
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network$1,261,638
U54 · FY2015 · AR · contact PI
Pathogenesis of Novel Forms of Osteogenesis Imperfecta$1,218,552
P01 · FY2015 · HD · contact PI
Phenylbutyrate therapy for maple syrup urine disease$606,154
R01 · FY2015 · DK · contact PI
Argininosuccinate lyase is an essential regulator of systemic nitric oxide produc$491,315
R01 · FY2015 · DK · contact PI
Medical Genetics Research Fellowship Program$407,890
T32 · FY2015 · GM · contact PI
Project 2. FKBP10 CHAPERONE COMPLEX AND TRAFFICKING AND ORGANELLE DYSFUNCTION IN$349,704
P01 · FY2015 · HD · contact PI
Project 1. PROLY 3-HYDROXYLASE (P3H) COMPLEX AND MATRIX CELL SIGNALING DEFECTS IN OSTEOGENESIS IMPERFECTA$328,889
P01 · FY2015 · HD · contact PI
Project 3. COLLAGEN POST-TRANSLATIONAL MODIFICATION AND CROSSLINKING IN HUMAN AN$288,630
P01 · FY2015 · HD · contact PI
Clinical Translational$245,549
U54 · FY2015 · HD · contact PI
Core A. GENOMICS CORE$173,536
P01 · FY2015 · HD · contact PI
Core B. ADMINISTRATIVE CORE$77,792
P01 · FY2015 · HD · contact PI
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network$1,258,097
U54 · FY2014 · AR · contact PI
Pathogenesis of Novel Forms of Osteogenesis Imperfecta$1,227,285
P01 · FY2014 · HD · contact PI
BCM CLINICAL SITE FOR AN UNDIAGNOSED DISEASES NETWORK (UDN)$800,000
U01 · FY2014 · HG · contact PI
Phenylbutyrate therapy for maple syrup urine disease$623,541
R01 · FY2014 · DK · contact PI
Argininosuccinate lyase is an essential regulator of systemic nitric oxide produc$491,315
R01 · FY2014 · DK · contact PI
Medical Genetics Research Fellowship Program$385,819
T32 · FY2014 · GM · contact PI
Project 2. FKBP10 CHAPERONE COMPLEX AND TRAFFICKING AND ORGANELLE DYSFUNCTION IN$352,440
P01 · FY2014 · HD · contact PI
Project 1. PROLY 3-HYDROXYLASE (P3H) COMPLEX AND MATRIX CELL SIGNALING DEFECTS IN OSTEOGENESIS IMPERFECTA$331,045
P01 · FY2014 · HD · contact PI
Project 3. COLLAGEN POST-TRANSLATIONAL MODIFICATION AND CROSSLINKING IN HUMAN AN$288,355
P01 · FY2014 · HD · contact PI
Clinical Translational$245,549
U54 · FY2014 · HD · contact PI
Core A. GENOMICS CORE$177,852
P01 · FY2014 · HD · contact PI
Core B. ADMINISTRATIVE CORE$77,593
P01 · FY2014 · HD · contact PI
2014 Bones and Teeth Gordon Research Conference and Gordon Research Seminar$3,001
R13 · FY2014 · AR · contact PI
Pathogenesis of Novel Forms of Osteogenesis Imperfecta$1,208,026
P01 · FY2013 · HD · contact PI
Phenylbutyrate therapy for maple syrup urine disease$618,167
R01 · FY2013 · DK · contact PI
Medical Genetics Research Fellowship Program$383,435
T32 · FY2013 · GM · contact PI
Argininosuccinate Lyase is an essential regulator of systemic nitric oxide produc$361,503
R01 · FY2013 · GM · contact PI
Project 2. FKBP10 CHAPERONE COMPLEX AND TRAFFICKING AND ORGANELLE DYSFUNCTION IN$348,928
P01 · FY2013 · HD · contact PI
Project 1. PROLY 3-HYDROXYLASE (P3H) COMPLEX AND MATRIX CELL SIGNALING DEFECTS IN$327,823
P01 · FY2013 · HD · contact PI
Project 3. COLLAGEN POST-TRANSLATIONAL MODIFICATION AND CROSSLINKING IN HUMAN AN$282,901
P01 · FY2013 · HD · contact PI
Core A. GENOMICS CORE$176,122
P01 · FY2013 · HD · contact PI
Core B. ADMINISTRATIVE CORE$72,251
P01 · FY2013 · HD · contact PI
2014 Bones and Teeth Gordon Research Conference and Gordon Research Seminar$15,000
R13 · FY2013 · AR · contact PI
Pathogenesis of Novel Forms of Osteogenesis Imperfecta$1,282,523
P01 · FY2012 · HD · contact PI
Phenylbutyrate therapy for maple syrup urine disease$656,180
R01 · FY2012 · DK · contact PI
Project 1. PROLY 3-HYDROXYLASE (P3H) COMPLEX AND MATRIX CELL SIGNALING DEFECTS IN$477,502
P01 · FY2012 · HD · contact PI
Argininosuccinate Lyase is an essential regulator of systemic nitric oxide produc$372,684
R01 · FY2012 · GM · contact PI
Project 2. FKBP10 CHAPERONE COMPLEX AND TRAFFICKING AND ORGANELLE DYSFUNCTION IN$325,196
P01 · FY2012 · HD · contact PI
Project 3. COLLAGEN POST-TRANSLATIONAL MODIFICATION AND CROSSLINKING IN HUMAN AN$257,445
P01 · FY2012 · HD · contact PI
Core A. GENOMICS CORE$148,821
P01 · FY2012 · HD · contact PI
Core B. ADMINISTRATIVE CORE$73,559
P01 · FY2012 · HD · contact PI
Urea Cycle Disorders Satellite Symposium: 11th International Meeting$6,000
R13 · FY2012 · HD
Pathogenesis of Novel Forms of Osteogenesis Imperfecta$1,353,454
P01 · FY2011 · HD · contact PI
Phenylbutyrate therapy for maple syrup urine disease$763,151
R01 · FY2011 · DK · contact PI
Project 1. PROLY 3-HYDROXYLASE (P3H) COMPLEX AND MATRIX CELL SIGNALING DEFECTS IN$512,376
P01 · FY2011 · HD · contact PI
In vivo function and tolerance to Factor VIII variants$383,750
R01 · FY2011 · HL · contact PI
Argininosuccinate Lyase is an essential regulator of systemic nitric oxide produc$372,684
R01 · FY2011 · GM · contact PI
Developmental Studies in the Skeletal Dysplasias$369,980
P01 · FY2011 · HD · contact PI
Project 3. COLLAGEN POST-TRANSLATIONAL MODIFICATION AND CROSSLINKING IN HUMAN AN$310,975
P01 · FY2011 · HD · contact PI
Project 2. FKBP10 CHAPERONE COMPLEX AND TRAFFICKING AND ORGANELLE DYSFUNCTION IN$250,464
P01 · FY2011 · HD · contact PI
Core A. GENOMICS CORE$173,391
P01 · FY2011 · HD · contact PI
Core B. ADMINISTRATIVE CORE$85,303
P01 · FY2011 · HD · contact PI
THERAPEUTIC AND STABLE ISOTOPIC INVESTIGATION OF THE UREA CYCLE DISORDERS$54,615
M01 · FY2011 · RR · contact PI
CLINICAL TRIAL: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, CROSS-OVER, ACTIVE-CONTROL$53,032
M01 · FY2011 · RR · contact PI
LONGITUDINAL STUDY OF UREA CYCLE DISORDERS$13,852
M01 · FY2011 · RR · contact PI
CLINICAL TRIAL: A PHASE 3, OPEN-LABEL STUDY OF THE SAFETY OF HPN-100 FOR THE LO$10,290
M01 · FY2011 · RR · contact PI
CLINICAL TRIAL: A PHASE 2, FIXED-SEQUENCE, OPEN-LABEL, SWITCH-OVER STUDY OF THE$7,124
M01 · FY2011 · RR · contact PI
CLINICAL TRIAL: A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, EFFICACY AND SAF$3,166
M01 · FY2011 · RR · contact PI
BONE MINERAL DENSITY IN PATIENTS WITH SKELETAL DYSPLASIAS$395
M01 · FY2011 · RR · contact PI
Pilot Project Program$1
U54 · FY2011 · HD · contact PI
Urea Cycle Disorders Satellite Symposium: 11th International Meeting$1
R13 · FY2011 · HD
In vivo function and tolerance to Factor VIII variants$383,750
R01 · FY2010 · HL · contact PI
Argininosuccinate Lyase is an essential regulator of systemic nitric oxide produc$376,448
R01 · FY2010 · GM · contact PI
Developmental Studies in the Skeletal Dysplasias$311,301
P01 · FY2010 · HD · contact PI
THERAPEUTIC AND STABLE ISOTOPIC INVESTIGATION OF THE UREA CYCLE DISORDERS$140,013
M01 · FY2010 · RR · contact PI
Dysregulation of 3-prolyl-hydroxylation in Human Skeletal Dysplasias$123,464
R01 · FY2010 · DE · contact PI
Pilot Project Program$46,926
U54 · FY2010 · HD · contact PI
CLINICAL TRIAL: A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, EFFICACY AND SAFE$12,590
M01 · FY2010 · RR · contact PI
LONGITUDINAL STUDY OF UREA CYCLE DISORDERS$11,445
M01 · FY2010 · RR · contact PI
ENTERAL PRECURSORS FOR UREA SYNTHESIS IN HUMANS$8,012
M01 · FY2010 · RR · contact PI
BONE MINERAL DENSITY IN PATIENTS WITH SKELETAL DYSPLASIAS$3,434
M01 · FY2010 · RR · contact PI
Urea Cycle Disorders Satellite Symposium: 11th International Meeting$1
R13 · FY2010 · HD
Argininosuccinate Lyase is an essential regulator of systemic nitric oxide produc$393,625
R01 · FY2009 · GM · contact PI
In vivo function and tolerance to Factor VIII variants$383,750
R01 · FY2009 · HL · contact PI
Transcriptional Regulation of Craniofacial Skeletogenesis$316,489
R01 · FY2009 · DE · contact PI
Developmental Studies in the Skeletal Dysplasias$305,284
P01 · FY2009 · HD · contact PI
Dysregulation of 3-prolyl-hydroxylation in Human Skeletal Dysplasias$121,079
R01 · FY2009 · DE · contact PI
Pilot Project Program$47,400
U54 · FY2009 · HD · contact PI
Urea Cycle Disorders Satellite Symposium: 11th International Meeting$28,000
R13 · FY2009 · HD
THERAPEUTIC AND STABLE ISOTOPIC INVESTIGATION OF THE UREA CYCLE DISORDERS$20,737
M01 · FY2009 · RR · contact PI